Welcome to our dedicated page for Omnicell news (Ticker: OMCL), a resource for investors and traders seeking the latest updates and insights on Omnicell stock.
Omnicell Inc. (OMCL) is a pioneering company that has been enhancing efficiencies in healthcare since 1992. As a leading supplier of comprehensive automation and business analytics software, Omnicell focuses on patient-centric medication and supply management across the entire healthcare continuum. This includes acute care hospital settings, post-acute skilled nursing and long-term care facilities, as well as home care settings.
Omnicell's automated hardware/software systems for medication dispensing provide seamless solutions from the point of hospital entry to the central pharmacy, nursing units, operating rooms, and patient bedsides. Their supply management systems are designed to promote cost control, ensure charge capture for payer reimbursement, and facilitate efficient inventory management and reordering.
Omnicell's range of products includes high-security, closed-cabinet systems, open-shelf systems, and combination systems that are used in nursing units, cath labs, and operating rooms. These solutions empower pharmacists and nurses to concentrate on patient care rather than administrative tasks, driving improved clinical, operational, and financial outcomes across diverse care settings. With over 3,200 customers worldwide, Omnicell continues to be a trusted partner in the healthcare sector.
In recent years, Omnicell has made significant strides in advancing their technology and expanding their service offerings. Their commitment to innovation is evident in the development of new products and partnerships that aim to further streamline medication management processes. Financially, the company generates the majority of its revenue in the United States, reflecting a strong market presence and consistent performance.
Omnicell announced changes to its Board of Directors, revealing that Jim Judson and Bruce Smith will not seek reelection at the 2022 Annual Meeting, reducing the board size to nine members. Mary Garrett has been nominated to join the board, enhancing its expertise in digital transformation and healthcare technology. Garrett's impressive background includes a lengthy tenure at IBM and current board positions at other companies. Additionally, Dan Johnston will retire as Executive VP and Chief Legal Officer. These moves are part of Omnicell's strategy to strengthen leadership and improve healthcare solutions.
Omnicell, a leader in medication management, has entered a 10-year agreement with UMC Health System in Lubbock, Texas, to implement its cloud-based solutions for pharmacy automation and patient engagement. This partnership aims to enhance operational efficiency and patient safety through advanced pharmacy technology.
With UMC's significant demand increase and high uninsured rates in Texas, the solutions are expected to improve health outcomes in underserved communities.
Omnicell's Autonomous Pharmacy vision will drive performance and allow clinicians to focus more on patient care.
Omnicell, Inc. (NASDAQ:OMCL) reported a robust performance in 2021, achieving total revenues of $1.132 billion, a 27% increase from the previous year. Fourth quarter revenues reached $311 million, marking a 25% year-over-year growth. The company ended 2021 with a product backlog of $1.254 billion and completed acquisitions to expand its service offerings. For 2022, Omnicell expects revenues between $1.385 billion and $1.410 billion, with guidance aiming for non-GAAP earnings of $3.75 to $3.95 per share.
Omnicell, Inc. (NASDAQ:OMCL) will release its financial results for Q4 and full-year 2021 on February 14, 2022, after market close. A conference call and webcast to discuss these results will follow at 1:30 p.m. PT the same day. Interested parties can participate by calling (888) 550-5424 in the U.S. or (646) 960-0819 internationally. Omnicell focuses on improving pharmacy care delivery through automation and technology, with over 7,000 facilities utilizing its solutions globally.
Omnicell has acquired MarkeTouch Media for
Omnicell has acquired ReCept Holdings for $100 million, enhancing its Advanced Services portfolio in specialty pharmacy management. The acquisition is projected to boost Omnicell's non-GAAP EBITDA starting Q1 2023, aligning with its strategy to address the complex specialty pharmacy market. ReCept reported annual recurring revenue of $24 million as of September 30, 2021. This addition allows Omnicell to optimize specialty pharmacy programs and improve patient care, further solidifying its position in medication management solutions.
Omnicell announced its strategic acquisition of ReCept Holdings for
Omnicell, Inc. (NASDAQ: OMCL) announced its participation in two upcoming investor conferences. Randall Lipps, Chairman and CEO, along with Scott Seidelmann, Executive VP, will present at the Piper Sandler 33rd Annual Virtual Healthcare Conference on December 1, 2021, at 9:00 am ET. Additionally, Peter Kuipers, Executive VP and CFO, will appear at the 2021 Stephens Annual Investment Conference on December 3, 2021, at 10:00 am CT in Nashville, TN. Webcasts of both presentations will be accessible on the Omnicell website.
Omnicell, Inc. (NASDAQ:OMCL) is collaborating with Fresenius Kabi to enhance pharmacy technology in U.S. hospitals. Their partnership introduces the Controlled Substance Dispenser (CSD), targeting improved management of controlled substances and increased efficiency in medication dispensing. This innovation aims to mitigate the significant loss of medication—over 148 million doses in 2019—which affects patient and workforce safety. The newly designed cassettes for Omnicell's CSD support Fresenius Kabi's MicroVault prefilled syringes, streamlining processes for healthcare providers.
Omnicell (NASDAQ: OMCL) announced the Tucson VA Medical Center as the first Veterans Affairs facility to implement its Central Pharmacy Dispensing Service (CPDS). This initiative aims to enhance patient safety, increase operational efficiency, and optimize inventory management in pharmacy operations. The partnership highlights Omnicell's commitment to transforming pharmacy care delivery through automation and technology, supporting the Veterans Health Administration's mission to serve 9 million veterans annually.
FAQ
What is the current stock price of Omnicell (OMCL)?
What is the market cap of Omnicell (OMCL)?
What is Omnicell Inc. known for?
When was Omnicell Inc. founded?
What types of healthcare settings does Omnicell serve?
How do Omnicell's products benefit healthcare providers?
What kinds of products does Omnicell offer?
How many customers does Omnicell have globally?
Where does Omnicell generate most of its revenue?
What recent achievements has Omnicell made?
How do Omnicell's supply management systems aid healthcare facilities?
What is the primary goal of Omnicell's products and services?
